Simplify Health Care ETF Rating $38.39 +0.21 (+0.55%) As of 09:41 AM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsNews and TrendsOwnershipRatingsShort Interest Simplify Health Care ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.PINK Aggregate RatingModerate Buy 2.64Holdings in PINK have an aggregate rating of Moderate Buy based on 481 analyst ratings issued in the past year covering 25 companies (92.6% of the portfolio).PINK Aggregate Price Target$38.18High Prediction$38.18Average Prediction$38.18Low Prediction$38.18Holdings in PINK have an aggregate price target of $38.18 and a range of $38.18 to $38.18 covering 25 companies (92.6% of the portfolio).PINK Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy1 Buy rating(s)Moderate Buy17 Moderate Buy rating(s)Hold7 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Simplify Health Care ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 PINK Holdings ExportWeight In ETFCompanyShare PriceConsensus RatingConsensus Price TargetPossible UpsideNumber of RatingsMarketRank™Indicator(s)ViewRatings9.91%LLYEli Lilly and Company$1,173.90+2.0%Moderate Buy$1,308.39 11.5%304.5507 of 5 starsTrending NewsAnalyst ForecastAnalyst Revision7.19%HUMHumana$373.81-0.3%Hold$403.91 8.1%304.4688 of 5 stars6.27%ARQTArcutis Biotherapeutics$26.380.0%Moderate Buy$35.57 34.9%93.8127 of 5 stars5.44%PCTPureCycle Technologies$5.06-1.8%Hold$11.75 132.4%33.0811 of 5 starsPositive News5.11%JNJJohnson & Johnson$274.40+1.9%Moderate Buy$274.13 -0.1%254.4149 of 5 starsTrending NewsAnalyst ForecastAnalyst Revision4.97%TMOThermo Fisher Scientific$666.53+0.2%Moderate Buy$624.64 -6.3%263.7782 of 5 starsTrending News4.85%ABBVAbbVie$265.11+0.0%Moderate Buy$276.64 4.3%253.8507 of 5 stars4.41%UNHUnitedHealth Group$369.55-0.5%Moderate Buy$456.56 23.5%274.9689 of 5 starsAnalyst Revision4.36%UTHRUnited Therapeutics$479.18-2.1%Moderate Buy$621.00 29.6%144.4329 of 5 starsAnalyst ForecastInsider Trade4.28%AVTRAvantor$14.94+1.2%Hold$12.47 -16.6%181.4025 of 5 stars3.76%WRBYWarby Parker$23.17-0.8%Moderate Buy$30.08 29.8%114.313 of 5 stars3.70%JAZZJazz Pharmaceuticals$234.90+0.0%Buy$289.37 23.2%184.4738 of 5 starsAnalyst Forecast3.49%DGXQuest Diagnostics$234.10+0.5%Moderate Buy$237.08 1.3%134.1587 of 5 starsAnalyst Forecast3.48%GILDGilead Sciences$150.90-0.3%Moderate Buy$158.78 5.2%293.4876 of 5 starsTrending NewsAnalyst Revision3.16%BNTCBenitec Biopharma$10.12+2.9%Moderate Buy$24.00 137.3%101.9287 of 5 starsUpcoming Earnings2.60%SMMTSummit Therapeutics$16.57+0.7%Hold$25.91 56.4%172.5213 of 5 starsAnalyst Forecast2.50%GHGuardant Health$175.18-0.6%Moderate Buy$188.13 7.4%262.172 of 5 stars2.30%AMGNAmgen$408.19+0.5%Hold$383.46 -6.1%303.6037 of 5 starsTrending NewsAnalyst ForecastAnalyst Revision2.14%BHVNBiohaven$13.53-1.0%Moderate Buy$18.69 38.1%172.9248 of 5 stars1.76%CVSCVS Health$85.31-0.6%Moderate Buy$107.24 25.7%234.8776 of 5 starsAnalyst Forecast1.73%CAHCardinal Health$222.68+0.6%Moderate Buy$266.56 19.7%194.7993 of 5 stars1.51%VRTXVertex Pharmaceuticals$524.24+1.5%Moderate Buy$573.83 9.5%233.7852 of 5 starsAnalyst Forecast1.49%TXG10x Genomics$77.59+2.6%Hold$44.00 -43.3%171.5049 of 5 starsAnalyst Forecast1.19%ESTAEstablishment Labs$66.87-1.3%Moderate Buy$100.25 49.9%92.9164 of 5 starsAnalyst ForecastGap Up0.99%GRALGRAIL$108.490.0%Hold$75.10 -30.8%120.9156 of 5 starsTrending NewsAnalyst ForecastInsider Trade This page (NYSEARCA:PINK) was last updated on 9/24/2026 by MarketBeat.com Staff. From Our PartnersA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...Porter & Company | SponsoredHow to get a stake in Anthropic — before the IPOAnthropic, the maker of Claude AI, has reportedly filed for an IPO that could arrive as early as October. Its ...Weiss Ratings | SponsoredWhy I believe the AI market will split in Q4Matt McCall, who recommended Nvidia near $6 a share, says the AI market is splitting in two - just like the do...The Oxford Club | SponsoredShocking new footage just releasedGerardo Del Real is calling it the Third Convergence Event, a new catalyst hitting the uranium market that he ...Digest Publishing | SponsoredCongress Passes Landmark Digital Asset Law Wall Street Is WatchingThe House passed the Digital Asset Market Clarity Act 294 to 134, creating the most comprehensive financial te...Awesomely | SponsoredIf you keep cash in a U.S. bank account… read this NOWSince 2020, U.S. banks have been required to keep zero percent of deposits on hand, lending out nearly every d...Banyan Hill Publishing | SponsoredTrump goes "all-in" on Grand Canyon energy breakthroughA drilling crew near the Grand Canyon uncovered a clean energy well producing nearly eight times the output of...Behind the Markets | SponsoredHe turned $12K into $1.65M without touching Apple or TeslaTim Sykes turned $12,415 in gift money into more than $1.65 million before graduating college, without trading...Tim Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Simplify Health Care ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Simplify Health Care ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
